|
Getting your Trinity Audio player ready...
|
Nicklaus Children’s Hospital is collaborating with other organizations in January to offer “GENEuary 2022,” a month-long program to promote understanding of the role of genetics and genetic testing in diagnosis and treatment of disease. During the month, the hospital’s Personalized Medicine and Health Outcomes team is hosting live and virtual events to share the latest developments in genomic medicine.
“We look forward to sharing our exciting work in genomic medicine and how it is improving care for children in our community and beyond. Many thrilling developments are emerging now, with many more coming in the years ahead,” said Darya Salyakina, PhD, Director of Personalized Medicine and Health Outcomes at Nicklaus Children’s.
Highlights of the GENEuary calendar include “Soar to Genomic Discovery,” to be held at 7:30 p.m. Thursday, January 6 at the Alper JCC, 4221 Pine Tree Drive Miami Beach, FL 33140 (Virtual participation is also possible. See link below.)
Speakers include:
- Stephen Kingsmore, MD, DsC, President/CEO of Rady Children’s Institute for Genomic Medicine, will address “The Future of Pediatric Genomic Medicine.”
- Dr. Reshma Naido, neuropsychologist, will speak on “How to be a family with a Differently Destined Child.”
- Darya Salyakina, PhD, Director of Personalized Medicine and Health Outcomes, will serve as event host.
In addition, the month-long series will include a variety of virtual opportunities available to clinicians and the public. For a complete list of virtual and in-person offerings for the month, please visit our website at: www.Nicklauschildrens.org/GENEuaryschedule
GENEuary program collaborators include Rady Children’s Institute for Genomic Medicine (San Diego, CA) the Miami Beach JCC, Alper JCC, David Posnack JCC, Michael Ann Russell JCC and Live Like Bella.
Nicklaus Children’s Hospital made a giant leap in embracing the genomic revolution in medical care in 2018, becoming the first and only pediatric hospital in the southeastern U.S. to implement personalized medicine at the bedside with the founding of its Personalized Medicine Initiative. Other highlights of the program include research that has validated the benefits of whole genome sequencing and rapid whole genome sequencing to support the care of children with undiagnosed genetic disorders.
